Biotech Startup Immunai Moving HQ to Alexandria Center for Life Science
By Aaron Short July 14, 2021 4:25 pm
reprints![](https://commercialobserver.com/wp-content/uploads/sites/3/2015/04/alexandria-center-for-life-science_450-east-29th-street_new-york-city.jpg?quality=80&w=755)
A biotech startup is leaving its 180 Varick Street headquarters for a new lab along a growing science-friendly corridor in Kips Bay.
Immunai, a company that has been developing technology to map a patient’s immune system, signed a deal this month to move into 12,288 square feet of laboratory and office space in the Alexandria Center for Life Science at 430 East 29th Street, according to brokers from CBRE.
The life sciences firm found its new home in the East River Science Park with help from CBRE’s John Isaacs and Christopher Menard. CBRE declined to provide the terms of the deal.
“Immunai is a very exciting company with a lot of potential in the immunotherapy space and we are thrilled to help them expand the life sciences sector of the city,” Isaacs said in a statement. “We are starting to see more companies graduate from incubator space and establish their own presence in New York City and Immunai’s lease speaks directly to this trend.”
The Israel- and New York-based company appears to be growing rapidly since its founding two years ago, having raised $20 million in seed funding last May and another $60 million in Series A funding in February, TechCrunch reported. Immunai already has the world’s largest database for single-cell immunity characteristics and uses machine-learning to enhance immunotherapies. Soon, Immunai will be able to generate new therapies based on the data it’s collected and analyzed.
“As we’ve grown our New York roster of software engineers, computational biologists, and immunologists … we realized our office space needed to grow with us,” Immunai’s CEO and co-founder, Noam Solomon, said in a statement. “In securing this lease … our team will have the space needed to continue our cutting-edge single-cell work.”
The First Avenue office tower has lured Pfizer, Eli Lilly and Roche to its 728,000-square-foot campus, featuring a digital conference center and event space, an urban farm, restaurants, a fitness center, and a waterfront esplanade overlooking the East River. Adam Kaufman from Alexandria Real Estate Equities repped the building owner in-house. The company did not respond to a request for comment.